SEEBRI


What it isAn inhaled long-acting muscarinic antagonist (LAMA) for COPD maintenance, alone or in fixed combinations.
Why this oneThe quaternary ammonium structure keeps it out of the CNS, delivering bronchodilation with minimal systemic anticholinergic burden.
What limits itIt is maintenance, not rescue, and the usual antimuscarinic cautions (narrow-angle glaucoma, urinary retention) still apply.
NO BOXED WARNINGS
Principal riskPeripheral anticholinergic effects; impaired sweating
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.